Kininogen-1 and insulin-like growth factor binding protein-6 as serum biomarkers for proliferative vitreoretinopathy

Chinese Journal of Ophthalmology

Volumn 46, Issue 7, 2010, Pages 609-614

  Wang, Fang ^a,b   Yu, Jing ^a   Qiu, Qing Hua ^a   Bai, Lin ^a   Cao, Hui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Biological markers; Insulin like growth factor binding protein 6; Kininogens; Proliferative; Vitreoretinopathy

Indexed keywords

BIOLOGICAL MARKER; KININOGEN; SOMATOMEDIN BINDING PROTEIN 6;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; VITREORETINOPATHY;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; KININOGENS; MALE; MIDDLE AGED; VITREORETINOPATHY, PROLIFERATIVE;

EID: 77956585472     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0412-4081.2010.07.007     Document Type: Article

References (19)

1. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol, 1995, 79: 953-960.
2. Chang YC, Hu DN, Wu WC. Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy. Am J Ophthalmol, 2008, 146: 440-446.
3. Yu J, Liu F, Cui SJ, et al. Vitreous proteomic analysis of proliferative vitreoretinopathy. Proteomics, 2008, 17: 3667-3678.
4. Bryant JW, Shariat-Madar Z. Human plasma kallikrein-kinin system: physiological and biochemical parameters. Cardiovasc Hematol Agents Med Chem, 2009, 7: 234-250.
5. Koike H, Ito K, Takezawa Y, et al. Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethyistilbestrol in hormone refractory prostate cancer. Br J Cancer, 2005, 92; 1538-1544. (Pubitemid 40705023)
6. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology, 1983, 90: 121-125.
7. Machemer R, Buettner H, Norton EW, et al. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol, 1971, 75: 813-820.
8. Cheema A, Peyman GA, Fang T, et al. Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging, 2007, 38: 365-370. (Pubitemid 350057916)
9. Asaria H, Charteris G. Proliferative vitreoretinopathy : developments in pathogenesis and treatment. Compr Ophthalmol Update, 2006, 7: 179-185. (Pubitemid 44453099)
10. Prasad A, Tsimikas S. Candidate biomarkers for the detection of coronary plaque destabilization and rupture. Curr Atheroscler Rep, 2008, 10: 309-317.
11. Crispen L, Boorjian A, Lohse M, et al. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer, 2008, 113: 450-460.
12. Isordia-Salas I, Sainz M, Pixley A, et al. High molecular weight kininogen in inflammation and angiogenesis : a review of its properties and therapeutic applications. Rev Invest Clin, 2005, 57: 802-813.
13. Gilbert C, Hiscott P, Unger W, et al. Inflammation and the formation of epiretinal membranes. Eye, 1988, 2 Suppl : S140-156.
14. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev, 2002, 23: 824-854. (Pubitemid 35454590)
15. Yasuoka H, Yamaguchi Y, Feghali-Bostwick CA. The Pro-fibrotic Factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. Am J Respir Cell Mol Biol, 2009, 4: 179-188.
16. Perks CM, Holly JM. IGF binding proteins (IGFBPs) and regulation of breast cancer biology. J Mammary Gland Biol Neoplasia, 2008, 13: 455-469.
17. Yang H, Chaum E. A reassessment of insulin-like growth factor binding protein gene expression in the human retinal pigment epithelium. J Cell Biochem, 2003, 89: 933-943. (Pubitemid 36927725)
18. Mukherjee S, Guidry C. The insulin-like growth factor system modulates retinal pigment epithelial cell fractional force generation. Invest Ophthalmol Vis Sci, 2007, 48: 1892-1899. (Pubitemid 351261379)